Shattuck Labs Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Shattuck Labs Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Austin
Headquarters state / province: Texas
Headquarters country: United States
Fiscal year end: December
Ticker symbol: STTK
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001680367
EIN: 81-2575858

Board of directors

Follow this board

Amy Kate Sasser · Director
Since 2024
Carrie Brownstein · Director
Since 2023
Clay B. Siegall · Director
Since 2024
Daniel G. Baker · Director
Since 2025
George Golumbeski · Director
Since 2023
Helen M. Boudreau · Director
Since 2023
Jeremy Green · Director
Since 2023
Michael Stewart Lee · Director
Since 2023
Mona Ashiya · Director
Since 2025
Neil W. Gibson · Director
Since 2023
Taylor Schreiber · Director · Chief Executive Officer
Since 2023
Tyler Brous · Director
Since 2023

Chief executives

Taylor Schreiber · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 11 other boards. 11 are in the same sector.

Shared director Other board Same sector

Fate Therapeutics Inc. Same sector
via Jeremy Green and Michael Stewart Lee
Absci Corporation Same sector
via Jeremy Green
Acumen Pharmaceuticals Inc. Same sector
via George Golumbeski
Artiva Biotherapeutics Inc. Same sector
via Daniel G. Baker
Atara Biotherapeutics Inc. Same sector
via Jeremy Green
Disc Medicine Inc. Same sector
via Mona Ashiya
Immunome Inc. Same sector
via Clay B. Siegall
Instil Bio Inc. Same sector
via Neil W. Gibson
Rallybio Corporation Same sector
via Helen M. Boudreau
Tvardi Therapeutics Inc. Same sector
via Helen M. Boudreau
Yarrow Bioscience Inc. Same sector
via Mona Ashiya

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $250,000; 1 purchase by 1 insider
Sold, last 12 months: $591,850; 6 sales by 2 insiders

Date	Insider	Transaction	Shares	Price	Value
Jul 6, 2026	Shukla Abhinav A. Officer (Chief Technical Officer)	Option exercise	+12,153	$3.57	$43,386
Jul 2, 2026	Shukla Abhinav A. Officer (Chief Technical Officer)	Option exercise	+410	$3.57	$1,464
Jul 2, 2026	Shukla Abhinav A. Officer (Chief Technical Officer)	Open-market sale	−410	$7.01	$2,874
Jul 1, 2026	Shukla Abhinav A. Officer (Chief Technical Officer)	Option exercise	+100	$3.57	$357
Jul 1, 2026	Shukla Abhinav A. Officer (Chief Technical Officer)	Open-market sale	−100	$7.07	$707
Jun 30, 2026	Pandite Arundathy N. Officer (Chief Medical Officer)	Open-market sale	−30,000	$7.01	$210,300
Jun 30, 2026	Shukla Abhinav A. Officer (Chief Technical Officer)	Option exercise	+23,365	$3.57	$83,413
Jun 30, 2026	Shukla Abhinav A. Officer (Chief Technical Officer)	Open-market sale	−23,365	$7.08	$165,424
Jun 9, 2026	Clay B. Siegall Director	Open-market purchase	+62,500	$4.00	$250,000
May 22, 2026	Clay B. Siegall Director	Grant or award	+128,054	$1.08	$138,298
May 21, 2026	Shukla Abhinav A. Officer (Chief Technical Officer)	Grant or award	+5,122	$1.08	$5,532
May 15, 2026	Stout Stephen Officer (See Remarks)	Grant or award	+12,805	$1.08	$13,829
May 12, 2026	Neill Andrew R Officer (Chief Financial Officer)	Grant or award	+64,027	$1.08	$69,149
May 12, 2026	Shukla Abhinav A. Officer (Chief Technical Officer)	Option exercise	+2,032	$3.57	$7,254
May 12, 2026	Pandite Arundathy N. Officer (Chief Medical Officer)	Open-market sale	−30,000	$6.61	$198,300

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Shattuck Labs Inc.

Who is the CEO of Shattuck Labs Inc.?

Taylor Schreiber is Shattuck Labs Inc.'s Chief Executive Officer.

How many directors are on Shattuck Labs Inc.'s board?

Shattuck Labs Inc.'s board has 12 directors: Amy Kate Sasser, Carrie Brownstein, Clay B. Siegall, Daniel G. Baker, George Golumbeski, Helen M. Boudreau, Jeremy Green, Michael Stewart Lee, Mona Ashiya, Neil W. Gibson and 2 others.

Are Shattuck Labs Inc. insiders buying or selling shares?

Over the last 12 months, Shattuck Labs Inc. insiders bought $250,000 of shares in 1 purchase and sold $591,850 of shares in 6 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Shattuck Labs Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="shattuck-labs-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.